Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials

BACKGROUND: : Coronavirus disease 2019 (COVID-19) is an emerging and rapidly evolving disease, with no recommended effective anti-coronavirus treatments. Traditional Chinese Medicine (TCM) has been widely used to treat COVID-19 in China, and the most used one is Lianhuaqingwen (LH). This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zheng, Guo, Guiming, Che, Xiaoping, Yang, Ying, Liu, Yang, Li, Luyang, Chang, Xinyu, Han, Lijuan, Cai, Xiaorong, Tang, Huilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154466/
https://www.ncbi.nlm.nih.gov/pubmed/34032734
http://dx.doi.org/10.1097/MD.0000000000026059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154466/
https://www.ncbi.nlm.nih.gov/pubmed/34032734
http://dx.doi.org/10.1097/MD.0000000000026059

Ejemplares similares